Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Sensodyne, a leading oral care brand from Haleon (formerly GlaxoSmithKline Consumer Healthcare), sets a GUINNESS WORLD RECORD™ for successfully attempting the ‘Most online dental screening tests ...

While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

Dental Screenings completed in 1 Day at Maha KumbhWorld Oral Health Day campaign will educate people on importance of good ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

With nearly two decades of experience across advertising, media, and marketing, Mansi Datta stands as one of the driving ...

Indian Pharmaceuticals Market has delivered marginally lower revenue at 7.5% year on year in February 2025, compared to 8.7% ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious than standard therapy alone, according to a new phase 3, placebo ...